Volume 84, Issue 5, Pages (November 2013)

Slides:



Advertisements
Similar presentations
Volume 76, Issue 9, Pages (November 2009)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Volume 80, Issue 1, Pages (July 2011)
Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome  Delma.
Volume 80, Issue 7, Pages (October 2011)
Volume 81, Issue 11, Pages (June 2012)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 76, Issue 9, Pages (November 2009)
Volume 69, Issue 6, Pages (March 2006)
Volume 66, Issue 1, Pages (July 2004)
Inhibition of ILK activity does not affect normal kidney structure and nephrin/ILK interaction in vivo. Inhibition of ILK activity does not affect normal.
Volume 85, Issue 4, Pages (April 2014)
Volume 80, Issue 12, Pages (December 2011)
Volume 78, Issue 4, Pages (August 2010)
Volume 86, Issue 1, Pages (July 2014)
Volume 88, Issue 4, Pages (October 2015)
Volume 73, Issue 12, Pages (June 2008)
Volume 72, Issue 4, Pages (August 2007)
Volume 68, Issue 3, Pages (September 2005)
Volume 90, Issue 1, Pages (July 2016)
Volume 85, Issue 6, Pages (June 2014)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 85, Issue 2, Pages (January 2014)
Proteomic analysis of the slit diaphragm complex: CLIC5 is a protein critical for podocyte morphology and function  Brian A. Pierchala, Maura R. Muñoz,
Volume 84, Issue 5, Pages (November 2013)
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 79, Issue 12, Pages (June 2011)
Proteinuria: an enzymatic disease of the podocyte?
Expression of HIV transgene aggravates kidney injury in diabetic mice
Volume 83, Issue 6, Pages (June 2013)
Volume 77, Issue 11, Pages (June 2010)
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Volume 87, Issue 2, Pages (February 2015)
Autophagy in proximal tubules protects against acute kidney injury
Volume 77, Issue 11, Pages (June 2010)
A new mouse model of immune-mediated podocyte injury
Volume 62, Issue 1, Pages (July 2002)
Volume 73, Issue 4, Pages (February 2008)
Liming Wang, Jae-Hyung Chang, Anne F. Buckley, Robert F. Spurney 
Volume 63, Issue 4, Pages (April 2003)
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Issue 2, Pages (February 2005)
Volume 75, Issue 10, Pages (May 2009)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 83, Issue 6, Pages (June 2013)
Volume 72, Issue 4, Pages (August 2007)
Volume 86, Issue 5, Pages (November 2014)
Volume 66, Issue 1, Pages (July 2004)
Volume 78, Issue 5, Pages (September 2010)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Volume 61, Issue 6, Pages (June 2002)
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 71, Issue 7, Pages (April 2007)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
Volume 82, Issue 3, Pages (August 2012)
Volume 68, Issue 2, Pages (August 2005)
Volume 69, Issue 11, Pages (June 2006)
Volume 85, Issue 1, Pages (January 2014)
Volume 73, Issue 9, Pages (May 2008)
R. Tapia, F. Guan, I. Gershin, J. Teichman, G. Villegas, A. Tufro 
Volume 131, Issue 5, Pages (November 2006)
Volume 73, Issue 12, Pages (June 2008)
Volume 58, Issue 3, Pages (September 2000)
Volume 55, Issue 4, Pages (April 1999)
Volume 68, Issue 1, Pages (July 2005)
Presentation transcript:

Volume 84, Issue 5, Pages 920-930 (November 2013) Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury  Simone M. Blattner, Jeffrey B. Hodgin, Masashi Nishio, Stephanie A. Wylie, Jharna Saha, Abdul A. Soofi, Courtenay Vining, Ann Randolph, Nadja Herbach, Ruediger Wanke, Kevin B. Atkins, Hee Gyung Kang, Anna Henger, Cord Brakebusch, Lawrence B. Holzman, Matthias Kretzler  Kidney International  Volume 84, Issue 5, Pages 920-930 (November 2013) DOI: 10.1038/ki.2013.175 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Targeted inactivation of Rac1 and Cdc42 in podocytes. (a) The diagram demonstrates the strategy for generation of podocyte-specific Rac1- and Cdc42-knockout mice. Mice expressing Cre-recombinase under control of the podocin promoter (2.5P-Cre) were bred with mice carrying floxed Rac1 locus (exon 3) and floxed Cdc42 locus (exon 2). (b) PCR analysis of genomic DNA from tail clippings. The PCR product band of floxed (280bp) and wild-type (200bp) Rac1 as well as floxed (300bp) and wild-type (200bp) Cdc42 are shown. In addition, the 2.5P-Cre PCR product band (268bp) is indicated. (c) Western blot analysis of Rac1 and Cdc42 in isolated glomeruli from podoRac1–/– and podoCdc42–/– mice with antibodies against Rac1, Cdc42, and β-actin reveals strong reduction of specific protein signal. (d) Survival curve for podoCdc42–/– and podoRac1–/– mice shows 100% mortality with loss of podocyte-specific Cdc42 by day 60. (e) SDS–polyacrylamide gel electrophoresis analysis of urine samples demonstrates variable selective proteinuria by 10 days of age in podoCdc42–/– mice and heavy nonspecific proteinuria by 16 days of age compared with floxed control. Loss of podocyte-specific Rac1 has no effect on urine protein at 6 months. (f) Urine albumin-to-creatinine ratios in podoCdc42–/– mice were significantly increased versus floxed controls (n=5 per group) (*P<0.05). (g) Whole kidneys from podoCdc42–/– mouse at 3 weeks of age are pale yellow and display a granular surface compared with floxed control. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 Progressive glomerulosclerosis in podoCdc42–/– but not podoRac1–/– mice by light microscopy (periodic acid–Schiff staining at × 20 and × 40 magnification). (a, b) Floxed control mice demonstrate normal tubulointerstitial and glomerular morphology at 3–4 weeks of age. (c, d) podoRac1–/– tubulointerstitial and glomerular morphology at 12 months of age is indistinguishable from control. Podocyte-specific loss of Cdc42 results in tubular protein casts and injury (e) as well as focal segmental glomerulosclerosis in a minority of glomeruli (f) at 3–4 weeks of age. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Severe podocyte foot process effacement in podoCdc42–/– but not podoRac1–/– mice by electron microscopy ( × 14,600 transmission and × 7000 scanning magnification). (a, b) Transmission and scanning electron micrographs of control mouse glomeruli show an intact arrangement of podocyte foot processes and normal filtration slits. (c, d) podoRac1–/– podocytes demonstrate no aberrant morphology and are indistinguishable from control. (e, f) In contrast, podoCdc42–/– mouse podocytes show total effacement of foot processes with near absence of filtration slits. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Glomerular mRNA and protein expression of podocyte markers from 1-month-old podoRac1–/– and podoCdc42–/– mice. (a) Gene expression for podocyte markers nephrin, podocin, and synaptopodin in podoRac1–/– glomeruli does not differ from floxed control. In contrast, isolated glomeruli from podoCdc42–/– mice display a significant reduction in transcript levels of nephrin and podocin compared with floxed control mice (*P<0.05). Synaptopodin gene expression is not significantly different. (b) Immunofluorescence studies from kidney sections stained with antibodies against nephrin, podocin, and synaptopodin demonstrate continuous distribution in podocytes from floxed control and podoRac1–/– mice. In contrast, immunofluorescence for nephrin and podocin in podocytes from podoCdc42–/– mice exhibit a significantly impaired, granular distribution along the basement membrane. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Total cofilin and phospho-cofilin (p-cofilin), the active and inactive states, respectively, in isolated glomeruli from podoRac1–/–, podoCdc42–/–, and floxed control mice by western and densitometry analysis. (a, c) Compared with all floxed controls, protein expression of p-cofilin/total cofilin in glomeruli from podoRac1–/– appear similar. In stark contrast, (b, d) podoCdc42–/– glomeruli display no appreciable p-cofilin, highlighting a significant imbalance in cofilin phosphorylation. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Normal phenotype in 1-week-old podoCdc42–/– mice. (a) SDS–polyacrylamide gel electrophoresis shows no albumin bands in urine from podocyte-specific Cdc42-knockout mice. (b) Tubulointerstitial and glomerular morphology demonstrates an immature appearance in both podoCdc42–/– and floxed control mice (periodic acid–Schiff staining at × 10 and × 40 magnification). (c) Ultrastructural examination reveals no difference in glomerular capillary or podocyte foot process (inset) morphology between floxed control (c) and podoCdc42–/– (d) mice. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Loss of podocyte-specific Rac1 protects against induction of podocyte foot process effacement by protamine sulfate. (a) Transmission electron microscopy (TEM) of glomerular capillary walls of floxed control mice after perfusion with HBSS control (top left) and protamine sulfate (top right) demonstrates partial foot process effacement (arrowheads). Glomerular capillary walls from podoRac1–/– mice after perfusion with HBSS control (bottom left) and protamine sulfate (bottom right) shows no qualitative difference in foot process morphology. Results are representative of 6–8 mice per group, × 7900 magnification. (b) Filtration slit frequency per micron as seen by TEM reflects the morphological interpretation. *P<0.05. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 8 Body weight, systolic blood pressure, and organ weights at 4 weeks following UNX/deoxycorticosterone acetate (DOCA)-salt treatment. (a) No difference in average total body weight among the four groups. (b–d) UNX/DOCA-salt treatment resulted in increased systolic blood pressure, kidney/body weight ratio, and left ventricle/body weight similarly in both podoRac1–/– and Rac1-fl/fl control mice. *P<0.01, **P<0.05. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 9 Albuminuria and percentage glomerulosclerosis in UNX/deoxycorticosterone acetate (DOCA)-salt mice. (a) Albumin-to-creatinine ratio at 1 week before, and 2 and 4 weeks after uninephrectomy and DOCA treatment demonstrate significantly more albuminuria in podoRac1–/– mice than Rac1-fl/fl control mice. (b) UNX/DOCA-salt–treated podoRac1–/– demonstrates twice the glomerulosclerosis than Rac1-fl/fl control mice. Sham-treated mice of both genotypes showed no glomerulosclerosis (data not shown). (c, d) Representative periodic acid–Schiff–stained glomerulus at × 20 and × 40 magnification from UNX/DOCA-salt–treated podoRac1–/– mouse demonstrating segmental sclerosis. *P<0.05, #P=0.19. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 10 Transmission electron microscopy (TEM). Glomerular capillary walls of UNX/deoxycorticosterone acetate (DOCA)-salt–treated Rac1-fl/fl (a) and podoRac1–/– (b) mice display focal and segmental foot process effacement. Sham-treated podoRac1–/– and Rac1-fl/fl (c) exhibit only normal appearing, regularly interdigitating podocyte foot processes. Kidney International 2013 84, 920-930DOI: (10.1038/ki.2013.175) Copyright © 2013 International Society of Nephrology Terms and Conditions